https://de.marketscreener.com/kurs/aktie/EVOTEC-SE-436047/news/Evotec-Boehringer-Ingelheim-und-bioMerieux-grunden-Aurobac-ein-Joint-Venture-zur-Bekampfung-ant-40904745/?utm_source=telegram&utm_medium=social&utm_campaign=share